You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API nilotinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing nilotinib

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	TASIGNA	nilotinib	0078-0526	CROSPOVIDONE
Novartis Pharmaceuticals Corporation	TASIGNA	nilotinib	0078-0526	FERRIC OXIDE RED
Novartis Pharmaceuticals Corporation	TASIGNA	nilotinib	0078-0526	FERRIC OXIDE YELLOW
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for nilotinib

Excipient focus: CROSPOVIDONE

nilotinib drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

nilotinib drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

nilotinib drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GELATIN

nilotinib drug variants containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing GELATIN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

nilotinib drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

nilotinib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLOXAMER 188

nilotinib drug variants containing POLOXAMER 188

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing POLOXAMER 188

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

nilotinib drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

nilotinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	nilotinib	0078-0526
>Company	>Ingredient	>NDC

nilotinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.